P
AGN

Pitcairn’s Allergan plc AGN Stock Holding History

Pitcairn’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,965
Closed -$525K – 537
2020
Q1 		$525K Buy
2,965
+134
+5% +$25.2K 0.06% 193
2019
Q4 		$541K Sell
2,831
-3,741
-57% -$675K 0.05% 242
2019
Q3 		$1.11M Sell
6,572
-2,328
-26% -$379K 0.11% 118
2019
Q2 		$1.49M Buy
8,900
+6,877
+340% +$952K 0.15% 96
2019
Q1 		$297K Sell
2,023
-72
-3% -$10.4K 0.03% 363
2018
Q4 		$280K Buy
2,095
+99
+5% +$16.2K 0.03% 328
2018
Q3 		$380K Sell
1,996
-15
-0.7% -$2.76K 0.04% 326
2018
Q2 		$336K Sell
2,011
-178
-8% -$28.6K 0.04% 361
2018
Q1 		$368K Sell
2,189
-990
-31% -$166K 0.04% 317
2017
Q4 		$520K Sell
3,179
-344
-10% -$61.7K 0.05% 260
2017
Q3 		$722K Sell
3,523
-194
-5% -$45.1K 0.08% 181
2017
Q2 		$904K Buy
3,717
+27
+0.7% +$6.34K 0.11% 130
2017
Q1 		$882K Hold
3,690
– – 0.11% 139
2016
Q4 		$775K Sell
3,690
-410
-10% -$84.9K 0.1% 159
2016
Q3 		$945K Buy
4,100
+35
+0.9% +$8.55K 0.12% 133
2016
Q2 		$939K Sell
4,065
-141
-3% -$32.5K 0.12% 124
2016
Q1 		$1.13M Sell
4,206
-187
-4% -$53.5K 0.14% 124
2015
Q4 		$1.37M Sell
4,393
-258
-6% -$76.8K 0.15% 99
2015
Q3 		$1.26M Sell
4,651
-6,004
-56% -$1.84M 0.17% 96
2015
Q2 		$3.23M Sell
10,655
-2,304
-18% -$687K 0.37% 40
2015
Q1 		$3.86M Buy
12,959
+36
+0.3% +$10.3K 0.43% 28
2014
Q4 		$3.33M Buy
12,923
+294
+2% +$73.5K 0.36% 44
2014
Q3 		$3.05M Sell
12,629
-145
-1% -$32.5K 0.34% 49
2014
Q2 		$2.85M Sell
12,774
-662
-5% -$137K 0.32% 52
2014
Q1 		$2.77M Sell
13,436
-1,845
-12% -$365K 0.31% 52
2013
Q4 		$2.57M Buy
15,281
+11,205
+275% +$1.75M 0.28% 60
2013
Q3 		$587K Sell
4,076
-585
-13% -$77.9K 0.07% 211
2013
Q2 		$589K Buy
+4,661
New +$528K 0.08% 223

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pitcairn's AGN Position: Q2 2020 in Review

Pitcairn sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,965 shares — an estimated $525K sold.

Pitcairn first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $3.86M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pitcairn reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pitcairn sold 2,965 Allergan plc shares in Q2 2020, an estimated $525K.
  • Pitcairn first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Pitcairn's Allergan plc position peaked at $3.86M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pitcairn's 13F filing for Q2 2020, filed 28 Jul 2020.